. Ruptures-de-stock, Agence Nationale de la Sécurité du Médicament (ANSM) Accessible sur http

R. Shretta and P. Yadav, Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up, Malaria Journal, vol.11, issue.1, pp.1-10, 2012.
DOI : 10.1002/hpm.822

K. K. Holmes, Azithromycin versus Penicillin G Benzathine for Early Syphilis, New England Journal of Medicine, vol.353, issue.12, pp.1291-1293, 2005.
DOI : 10.1056/NEJMe058161

A. V. Gundlapalli, S. E. Beekmann, D. R. Graham, and P. M. Polgreen, Perspectives and concerns regarding antimicrobial agent shortages among infectious disease specialists. Diagnostic microbiology and infectious disease, pp.75-256, 2013.
DOI : 10.1016/j.diagmicrobio.2012.11.020

H. Conseil-de-santé-publique, Avis relatif à l'utilisation des vaccins contre la typhoïde pour faire face aux difficultés d'approvisionnement prévisibles en raison de retrait de lots du vaccin Typhim Vi® Accessible sur http://ansm.sante.fr/S-informer/Informations- de-securite-Ruptures-de-stock-et-arrets-de-commercialisation-des-medicaments/TYPHERIX- solution-injectable-en-seringue-pre-remplie-Vaccin-typhoidique-polyosidique-Rupture-de-stock, 2012.

M. H. Scheetz, Prospective approach to managing antimicrobial drug shortages, Infection Control and Hospital Epidemiology, vol.33, issue.7, pp.745-752, 2012.